Latest Shareholder Protection News

Reliance Worldwide Corporation has agreed to an exclusivity period with Brookfield Capital Partners over a A$4.75 per share acquisition proposal, valuing the company at around A$4.1 billion. The deal includes a 30-day go-shop provision allowing alternative bids.

Scalare Partners offers 87 bonus options per 100 shares to eligible shareholders alongside piggyback options, aiming to mitigate dilution from upcoming convertible note conversions. Directors plan to exercise their options, with potential capital raised earmarked for working capital.

Keybridge Capital Limited confirms ongoing financial support from WAM Active and outlines plans to meet overdue reporting obligations ahead of a potential ASX delisting.

Cluey Ltd has formally requested voluntary delisting from the ASX, with the exchange agreeing in principle subject to shareholder approval and regulatory conditions. A general meeting is scheduled for 13 August 2026 to vote on the proposal.

Freedom Bidco has increased its unsolicited cash offer for Strata Investment Holdings to A$0.22 per share, presenting shareholders with a premium liquidity option ahead of Strata’s imminent ASX delisting. The offer includes a cash alternative and a share swap, while Freedom Bidco accuses Strata’s board of obstructive tactics and governance failings.

Freedom Bidco, Inc. has launched a non-binding cash proposal to acquire all Strata shares at A$0.16 each, matching the last traded price before suspension and offering shareholders a rare liquidity event ahead of Strata's expected ASX delisting.

Matrix Composites & Engineering has agreed to a full acquisition by Advanced Innergy Holdings at $0.40 per share, delivering shareholders a premium of up to 68% over recent trading prices. The deal, backed unanimously by Matrix’s board, awaits shareholder and court approval with completion targeted for July 2026.

Little Green Pharma Ltd (ASX: LGP) has proposed a full acquisition of Cannatrek Ltd via a scheme of arrangement, creating a vertically integrated medicinal cannabis group with pro forma FY26 revenues exceeding AUD 100 million. The scheme, supported by an independent expert, offers liquidity and strategic growth opportunities amid regulatory and market risks.

Future Metals NL has outlined strategic initiatives to enhance its flagship Panton PGM Project, leveraging rising platinum group metal prices and new processing opportunities. Key work programs and management appointments position the company for accelerated development in 2026.

Apiam Animal Health Limited shareholders are set to vote on a scheme of arrangement offering $0.87 cash per share or a mix of cash and unlisted scrip in a new holding company controlled by Adamantem Capital. The Independent Expert deems the cash offer fair and reasonable, while scrip options carry liquidity and minority risks.

Acorn Capital Investment Fund Limited (ACQ) reported a strong FY25 performance with a 15.1% net return and declared 5.5 cents per share in dividends, reinforcing its position in the Australian microcap sector.

Group One Capital Limited has adopted a comprehensive replacement Constitution at its 2025 Annual General Meeting, setting a refreshed governance framework aligned with current regulatory standards.